Common Stock, $0.16 par value per share
- Symbol
- NEOG
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Current Report · Items 5.07, 9.01 · 8-K
Neogen Corporation
NEOGNASDAQEQUITYCurrent
Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders. On October 1, 2026, the Company held its 2026 Annual Meeting of Shareholders. At the meeting, 176,180,487 of the 218,106,005 shares outstanding and entitled to vote were present and voted. The matters listed below were submitted to a vote of the shareholders though the solicitation of proxies.…
Company context
Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. A world leader in these fields, Neogen has a presence in over 140 countries with a dedicated network of scientists and technical experts focused on delivering optimized products and technology for its customers.
Current securities
Registered securities in this filing
Neogen Corporation · 8-K · Filed 2026-10-07
Disclosure sections
Item 5.07Item 5.07 - Submission of Matters to Vote
Item 5.07 Submission of Matters to a Vote of Security Holders.
On October 1, 2026, the Company held its 2026 Annual Meeting of Shareholders. At the meeting, 176,180,487 of the 218,106,005 shares outstanding and entitled to vote were present and voted. The matters listed below were submitted to a vote of the shareholders though the solicitation of proxies. The proposals are described in detail in the Company’s Proxy Statement dated as of, and filed with Securities and Exchange Commission on, August 21, 2026. The voting results are as follows:
Proposal 1 - Election of Directors
Nominee For Withheld
───────────────────────────────────────────────────────────────────────────────────────
Aashima Gupta 146,152,766 10,476,533
Raphael A. Rodriguez 155,080,607 1,548,692
Catherine E. Woteki, Ph. D. 154,950,353 1,678,946
Proposal 2 - To Approve, on an Advisory Basis, the Compensation of the Company’s Named Executive Officers
The shareholders approved, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the proxy materials.
For Against Abstain Broker Non-Vote
─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
151,434,206 2,498,510 2,677,583 19,551,188
Proposal 3 - Ratification of the Appointment of the Company’s Independent Registered Public Accounting Firm
The shareholders ratified the appointment of BDO USA, P.C. as the Company’s auditors for the fiscal year ending May 31, 2027.
For Against Abstain Broker Non-Vote
───────────────────────────────────────────────────────────────────────────────────────────────────
172,788,682 927,148 2,445,657
Proposal 4 - To Approve the Neogen Corporation Amended and Restated Omnibus Incentive Plan
The shareholders approved the Neogen Corporation Amended and Restated Omnibus Incentive Plan, as disclosed in the proxy materials.
For Against Abstain Broker Non-Vote
─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
150,242,832 3,815,133 2,552,334 19,551,188
Proposal 5 - To Approve an Amendment to the Neogen Corporation Employee Stock Purchase Plan
The shareholders approved the Amendment to the Neogen Corporation Employee Stock Purchase Plan to increase the number of shares available for issuance pursuant to the plan, as disclosed in the proxy materials.
For Against Abstain Broker Non-Vote
───────────────────────────────────────────────────────────────────────────────────────────────────────────────────
153,486,408 629,715 2,494,176 19,551,188